SHILPA PREM is an Associate in the Health Care and Life Sciences practice, in the New York office of Epstein Becker Green.
Represents clients in FDA drug, medical device, and biological approval- and clearance-associated matters
Represents health care entities in mergers, acquisitions, joint ventures, governance issues, and private equity and venture capital investments
Assists medical device and health care technology companies with FDA-regulation compliance matters, including current good manufacturing practices and quality systems, post-market surveillance and safety reporting, recalls, warning letter responses, and advertising and promotion
Articles in the National Law Review database by Shilpa Prem